Hari Deshpande, MD
Sarcomas are a rare type of cancer affecting less than 20,000 patients a year in the United States. I see patients who need systemic therapy (chemotherapy, immunotherapy or targeted therapy) as part of their management. I work closely with the sarcoma surgeons including Deiter Lindskog who runs the sarcoma program. Patients are presented at our multidisciplinary tumor board and may be candidates for one of our clinical trials.
I also treat patients with thyroid cancers and I am a member of the head and neck cancer and GU cancer teams.
Finally I am the Director of the Medical Oncology Consult service in charge of caring for patients who are admitted to Yale New Haven Hospital with a new cancer diagnosis.
It is an honor for me to care for our patients and work with the wonderful employees at the Yale Cancer Center and Smilow Cancer Hospital.
- Associate Professor of Medicine (Medical Oncology)
Education & Training
- FellowMontefiore Medical Center (1998)
- ResidentAlbert Einstein College of Medicine/Jacobi Medical Center (1995)
- MDLeeds University (1991)
- BSLeeds University (1988)